Urgent.News

What's breaking now, across thousands of outlets.

Business

Netweb Technologies shares fall 4% after raising Rs 1,200 crore through QIP

Netweb Technologies shares fell nearly 4% after the company completed its Rs 1,200 crore Qualified Institutions Placement (QIP), its first equity capital raise since listing in July 2023. The issue drew strong participation from global and domestic institutional investors, including Nomura, Goldman Sachs Asset Management and several mutual funds. The company will use the proceeds to meet working…

Netweb Technologies' shares experienced a 4% decline on Tuesday, plummeting to a low of Rs 5,220 on the NSE following the company's announcement of successfully completing its Rs 1,200 crore Qualified Institutional Placement (QIP). The QIP, the company's first equity capital raised since listing on the NSE and BSE in July 2023, garnered attention from global and domestic investors, with major players including Goldman Sachs, Nomura, and various mutual funds showing strong interest.

Written by urgent.news from The Economic Times - Top News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at economictimes.indiatimes.com →

More in Business

SK hynix Union Rejects Tentative Labor Deal by 25 Votes

SK hynix's tentative wage and collective bargaining agreement was rejected by just 25 votes, sending the company and its union back to the negotiating table.

  • SK hynix union rejects tentative labor deal by 25 votes
  • 50.08% of 16,083 members voted against the agreement
  • Workers concerned about shift from cash-based compensation system

Korea Targets 100 GW of Renewable Energy by 2030

South Korea has unveiled a detailed plan to expand the country's renewable energy capacity to 100 gigawatts by 2030, as securing a stable supply of renewable power emerges as a key factor in the…

  • South Korea aims to reach 100 GW renewable energy capacity by 2030.
  • Government to discuss strategy with industry leaders at August 26 roundtable.
  • Plans include simplifying permitting, new market structure, and grid upgrades.

K-Bio Licensing Deals Top $12 Billion, Near Record High

South Korea's pharmaceutical and biotech industry is on track to set a new annual record for overseas licensing deals, with the cumulative value of deals signed by domestic companies this year…

  • K-Bio licensing deals surpass $12 billion, nearing record high
  • Hanmi Pharmaceutical signs $2.3B obesity drug deal with Genentech
  • Korean biotech startups increase licensing activity to $625M

More from Tuesday 25 August →